What is it about?
Intermittent simvastatin vs fenofibrate in hemodialysis
Featured Image
Why is it important?
Our study was to Evaluate and compare the efficacy and safety of intermittent low dose fenofibrate (100 mg) versus simvastatin (20 mg) in chronic HD. Moreover, We also evaluated patients’ compliance using this simplified intermittent regimen.
Read the Original
This page is a summary of: Randomized comparative efficacy and safety study of intermittent simvastatin versus fenofibrate in hemodialysis, Journal of Comparative Effectiveness Research, June 2017, Future Medicine,
DOI: 10.2217/cer-2016-0076.
You can read the full text:
Contributors
The following have contributed to this page
